Full Value Chain

Focusing on therapeutic areas including oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infective therapies, we explore innovative products with disruptive or best-in-class potential through internal R&D and overseas partnerships. 

While addressing significant clinical gaps, we also prioritize market potential and commercial synergy.

We have international-standarded manufacturing facilities and our factories have achieved full business process informatization for industrial operations. We follow the global drug quality control standards to fulfill our commitment of being patient-centered.

We are one of the few local biopharmaceutical companies with a global supply chain management capability that ensures us to have sustainable product supply and cost advantages, establish competitive barriers, and acquire conditions for the continuous acquisition and localization transfer of subsequent pipeline products in the future.

Our academic-oriented sales and marketing strategy and data-based efficient operation improve drug accessibilities to the market. We dedicate to benefit more patients  from our classic products and innovative drugs.